New research suggests that a majority of patients with endometrial cancer may have tumors with a HER2 score of 2+ or higher.

The histopathology exam revealed a primary well-differentiated (grade 1) endometrioid adenocarcinoma of the fallopian tube. This patient had a strong family history of breast and ovarian cancers ...

Sometimes, the endometrial lining is abnormally thick or thin, which can impact your ability to become pregnant and can cause ...

Endometriosis, a condition where uterine-like tissue grows outside the uterus, has been linked to an increased risk of certain types of ovarian cancer, particularly endometrioid and clear-cell cancers ...

Histologic type was only available for 50% of the cancers and the authors commented that “most were endometrioid adenocarcinomas.” This is important because the traditional teaching that ...

Aadi will pause new enrollment but continue dosing previously enrolled patients in two ongoing Phase 2 trials of nab-sirolimus for advanced or recurrent endometrioid-type endometrial cancer (EEC ...

The dose-expansion phase will focus on evaluating NXP800 in patients selected using biomarker analysis, initially in clear cell ovarian and endometrioid ovarian cancers. Preclinical studies in cancer ...

Narazaciclib is under clinical development by Traws Pharma and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase I drugs for Colorectal Cancer have a 75% phase transition ...

In pre-clinical studies, NXP800 was shown to potently block human cancer cell growth in culture and cause regression of tumours in mice – with hard-to-treat ovarian clear cell carcinoma (OCCC) and ...

Genmab A/S (Nasdaq: GMAB) announced today new data from the Phase 1/2 study of rinatabart sesutecan (Rina-S), an investigational folate receptor-alpha ...